Patent · US Expired

Substituted N-phenylpiperidines and drugs therefrom

US5296485A · kind A · utility

7Cited by

5References

3Claims

0Family size

Assignee

BASF SE

Inventors

Wilfried Lubisch · Mannheim, DE
Sabine Schult · Speyer, DE
Berthold Behl · Ludwigshafen, DE
Michael Kirchengast · Speyer, DE

Key dates

Filing date	Mar 11, 1992
Grant date	Mar 22, 1994
Priority date	—
Expiry date	Mar 11, 2012

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D211/58
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Substituted N-phenylpiperidines I ##STR1## (R.sup.1 =H, NO.sub.2, CN, halogen, C.sub.1 -C.sub.4 -alkyl, CF.sub.3, OCF.sub.3, OH, CH.sub.2 OH, COOH, CHO, NH--CHO, NH.sub.2, CO--NH.sub.2, 5-tetrazinyl, R.sup.4 --O--, R.sup.4 --O--CH.sub.2 --, R.sup.4 O--CO--, R.sup.4 --CO--, R.sup.4 --NH--CO, R.sup.4 --CO--NH--, R.sup.4 --SO.sub.2 --NH--; PA0 R.sup.2 =H, NO.sub.2, halogen, C.sub.1 -C.sub.4 -alkyl or R.sup.4 --O--; ##STR2## R.sup.4 =C.sub.1 -C.sub.4 -alkyl or phenyl which can carry one of the R.sup.2 radicals; PA0 R.sup.5, R.sup.6 =H or one of the R.sup.4 radicals; R.sup.7 =one of the R.sup.1 radicals; PA0 n=0 or 1; m=1 or 2; with the proviso that R.sup.3 is ##STR3## only when n is 1, and the optical isomers in the case of optical isomerism, and the physiologically tolerated acid addition salts, are suitable as drugs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.